Human iPSC platform for ASO efficacy and CNS safety screening
Fact Sheet: Ncyte® Plate-Ready vCardiomyocytes
Fact Sheet: Ncyte® NHP-C vCardiomyocytes
Development of robust iPSC-based α-Synuclein, Tau and TDP-43 aggregation models for drug discovery
A human scalable platform for high-throughput screening of drug candidates targeting pathological aggregation of TAU, αSynuclein and TDP-43
Building manufacturing processes for reproducible, multi-yeariPSC-based drug screening
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
